DEVELOPMENT SITE ONLY
Please use current guidelines available on the UHNM intranet for patient treatment
Please use current guidelines available on the UHNM intranet for patient treatment
DEFINITION
Subarachnoid haemorrhage (SAH) is bleed into the subarachnoid space and non-traumatic cases are usually due to rupture of an intracranial aneurysm.
RECOGNITION AND ASSESSMENT
Symptoms and signs
- Severe headache of sudden onset implies SAH until proved otherwise
- headache becomes severe within seconds, peaking in 1–5 min
- may be associated with vomiting and loss of consciousness
- may be subsequent photophobia and neck stiffness
- Symptoms sometimes resolve within a few hours but still investigate with CT scan of head
- 30% of patients with SAH may have ‘minor’ leaks hours or days before the major haemorrhage, which are often misdiagnosed as simple headaches or migraine
- Unexplained coma or seizures with subsequent persistent severe headache can indicate acute SAH
- Examination may be normal
- Signs include neck stiffness, photophobia, intraocular haemorrhages (on fundoscopy), dilated pupils, focal findings (unilateral weakness, loss of visual fields and dysphasia)
Investigations
Baseline investigations
- FBC and clotting profile
- UEC and serum glucose
- ECG
CT scan of head
- Within 6 hr of onset of symptoms, but no longer than 24 hr of admission
Lumbar Puncture
- If initial CT normal (especially if performed more than 24-72 hr after initial headache onset) and clinical suspicion for SAH high, perform lumbar puncture at least 12 hr after symptom onset
- exclude SAH completely by analysis of CSF
- see Lumbar puncture guideline
Analysis of CSF
- Opening pressure
- Send sample to clinical biochemistry immediately for centrifugation to allow CSF spectrophotometry for xanthochromia
- if tap was traumatic, this is especially important
- record time from headache onset in hours/days on CSF xanthochromia request card to allow best assessment
- protect sample from light and warn clinical biochemistry before you send sample
- do not use air tube to transport sample
- MC&S, glucose and protein
- send blood for glucose, protein and bilirubin with CSF sample
Differential diagnosis
- Meningitis
- Encephalitis
- Cerebral venous sinus thrombosis (with raised opening pressure)
IMMEDIATE MANAGEMENT
- If consciousness impaired, check airway and maintain it
- Codeine phosphate 60 mg oral (or IM) 4-hrly as required up to maximum 240 mg in 24 hr
- Observe respiratory effort and monitor ECG
- If SAH confirmed, bleep on-call neurosurgical SpR, and request transfer to neurosciences
SUBSEQUENT MANAGEMENT
- First discuss with neurosciences team
Medication
- Nimodipine 60 mg oral 4-hrly including throughout night
- commence within 4 hr of SAH or as soon as diagnosis confirmed
- if unconscious, crush tablets and give immediately via nasogastric tube
- Manage blood pressure - see Acute stroke guideline - Immediate treatment, Blood pressure
Supportive therapy
- If no contraindication, give maintenance IV fluids – see maintenance IV fluid guideline
- Arrange for nursing staff to measure patient's legs and fit TED stockings
If improving and stable
- In confirmed SAH, consider CT angiography at earliest opportunity with a view to operative therapy - discuss with interventional neuroradiology and neurosurgery to determine best mode of intervention
If not improving or deteriorating
- Think about:
- metabolic cause (diabetes insipidus, hyponatraemia, hypoxia)
- hydrocephalus
- acute rebleed
- Consider further CT scan of head
MONITORING TREATMENT
- Until headache has subsided and patient stable, monitor 4-hrly:
- Glasgow coma score
- neurological observations
- pulse
- BP
- temperature
- When stable, monitor BP at least twice daily in patients taking nimodipine
DISCHARGE AND FOLLOW-UP
- If no operative intervention planned, continue oral nimodipine for a total of 21 days
- Discharge after 2-4 weeks and review in out-patient clinic
- If patient hypertensive, treat BP according to national guidelines e.g. British Hypertension Society